Neuss, Germany

Karl-Heinz Nietsch

USPTO Granted Patents = 1 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Karl-Heinz Nietsch

Introduction

Karl-Heinz Nietsch, located in Neuss, Germany, is an accomplished inventor known for his significant contribution to the field of pharmaceuticals. With a focus on innovative preparations for the topical administration of antiandrogenic substances, he has made strides in addressing various skin and hair disorders.

Latest Patents

Nietsch holds a patent titled "Preparations for Topical Administration of Substances Having Antiandrogenic Activity." This invention encompasses a formulation that includes lipid nanoparticles or a nanoemulsion containing at least one compound designed to combat androgenic alopecia and hirsutism, while also proving beneficial against seborrhea and acne. Notably, the formulation can be used in cosmetics, highlighting its versatility and potential market applications.

Career Highlights

He currently works with Aventis Pharma Deutschland GmbH, where he has been instrumental in developing novel therapies that target hormonal-related challenges facing many individuals today. His expertise and dedication to innovation have solidified his reputation within the pharmaceutical industry.

Collaborations

Throughout his career, Karl-Heinz Nietsch has collaborated with esteemed colleagues, including Karl Theodor Kraemer and Rainer Pooth. Together, they have shared insights and fostered an environment of innovation, ultimately enhancing the quality of their research and development projects.

Conclusion

With a focus on antiandrogenic therapies, Karl-Heinz Nietsch exemplifies the spirit of innovation within the pharmaceutical space. His contributions not only reflect his prowess as an inventor but also underscore the importance of collaborative efforts in advancing medical solutions. As he continues his work at Aventis Pharma, the impact of his inventions is sure to resonate in the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…